Bolt Biotherapeutics Inc. (BOLT)
NASDAQ: BOLT
· Real-Time Price · USD
5.35
0.08 (1.61%)
At close: Sep 11, 2025, 3:59 PM
5.38
0.56%
After-hours: Sep 11, 2025, 05:29 PM EDT
Bolt Biotherapeutics Revenue Breakdown
| Period Ending | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 |
|---|---|---|---|---|---|---|---|---|---|
| Consolidated Revenue | 11.91M | n/a | n/a | n/a | n/a | n/a | -322K | -243K | -151K |
| Consolidated Revenue Growth | n/a | n/a | n/a | n/a | n/a | -100.00% | +32.51% | +60.93% | n/a |
| Corporate Headquarters and Eliminations Revenue | n/a | 682K | 755K | 1.38M | 1.66M | 855K | 211K | 134K | 102K |
| Corporate Headquarters and Eliminations Revenue Growth | -100.00% | -9.67% | -45.45% | -16.73% | +94.39% | +305.21% | +57.46% | +31.37% | n/a |
| Seismic Energy Source Controllers Revenue | 313K | 5.32M | 4.79M | 7.88M | 6.28M | 5.71M | n/a | n/a | n/a |
| Seismic Energy Source Controllers Revenue Growth | -94.11% | +11.12% | -39.29% | +25.57% | +9.99% | n/a | n/a | n/a | n/a |
| Seismic Energy Sources Revenue | 3.67M | 3.96M | 3.76M | 4.45M | 5.15M | 5.49M | 111K | 109K | 49K |
| Seismic Energy Sources Revenue Growth | -7.35% | +5.32% | -15.45% | -13.56% | -6.25% | +4845.05% | +1.83% | +122.45% | n/a |
| Underwater Cables and Connectors Revenue | 2.46M | 3.89M | 6.41M | 8.03M | 3.12M | 5.87M | n/a | n/a | n/a |
| Underwater Cables and Connectors Revenue Growth | -36.80% | -39.41% | -20.11% | +157.17% | -46.81% | n/a | n/a | n/a | n/a |
| Underwater Robotic Vehicles Revenue | 5.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Underwater Robotic Vehicles Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2014 | Jun 30, 2013 |
|---|---|---|
| Foreign Countries Revenue | 42.38M | 35.68M |
| Foreign Countries Revenue Growth | +18.79% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.52M | 3.83M | 3.95M | 3.8M | 4.87M | 5.84M | 5.53M | 5.76M | 5.62M | 5.62M | 5.61M | 5.49M | 5.53M | 6.3M | 5.1M | 4.94M | 4.05M | 4.3M | 2.06M | 2.87M | 2.01M | 2.12M | 2.14M | 1.3M | 872.5K | 872.5K |
| Selling, General, and Administrative Revenue Growth | -8.08% | -3.09% | +3.90% | -22.06% | -16.50% | +5.49% | -3.94% | +2.47% | +0.09% | +0.18% | +2.21% | -0.85% | -12.25% | +23.63% | +3.20% | +21.88% | -5.70% | +108.89% | -28.17% | +42.47% | -5.23% | -0.70% | +64.38% | +49.00% | 0.00% | n/a |
| Research and Development Revenue | 7.5M | 9.51M | 11.72M | 13.79M | 15.43M | 16.07M | 15.82M | 14.95M | 15.64M | 14.63M | 16.84M | 18.97M | 18.92M | 18.39M | 22.48M | 19.34M | 19.71M | 14.13M | 14.86M | 9.54M | 9.17M | 6.79M | 7.43M | 6.24M | 6.16M | 6.16M |
| Research and Development Revenue Growth | -21.17% | -18.85% | -14.97% | -10.68% | -3.97% | +1.55% | +5.85% | -4.43% | +6.97% | -13.18% | -11.22% | +0.28% | +2.91% | -18.23% | +16.27% | -1.88% | +39.50% | -4.96% | +55.81% | +4.08% | +35.05% | -8.72% | +19.19% | +1.19% | 0.00% | n/a |